Interleukin-6 Biomarker as Possible Predicator of Preeclampsia
DOI:
https://doi.org/10.48112/bcs.v1i4.303Abstract
Abstract Views: 129
Preeclampsia (PE) is a serious illness that can harm both mothers and unborn children and may even be fatal. It contributes significantly to maternal fatalities in underdeveloped countries. PE, which affects 2%–3% of women who are pregnant after 20 weeks of pregnancy, is marked by proteinuria and hypertension. PE is a significant condition that plays a significant role in maternal fatalities in underdeveloped countries and is a significant cause of death for both mothers and newborns. Each year, around 60,000 maternal fatalities occur in the world. Serum interleukin-6 (IL-6) was measured in pregnant women during the first trimester and second trimesters. IL-6 was necessary to establish serum biomarkers that can accurately predict the onset of preeclampsia. In a prospective cohort study that was conducted in the Obstetrics and Gynecology Department and Antenatal Care Unit at Maternity and Pediatrics Teaching Hospital in AL-Diwaniyah – Iraq, 160 pregnant patients between the years of 20 and 40 who were normotensive and had gestational ages of 10 to 13 weeks were included in this research between August 2021 and May 2022. Bioassays for IL-6 were conducted after blood samples were obtained. At the end of the study, it was confirmed that for women with pre-eclampsia (n = 33, 22.0%) and those women with no pre-eclampsia (n = 117, 78.0 %), there was no significant difference in the level between the preeclampsia and no preeclampsia group (p > 0.05).
Keywords:
Preeclampsia, Interleukin-6, Hypertension, Pregnancy
Metrics
References
Aggarwal, R., Jain, A. K., Mittal, P., Kohli, M., Jawanjal, P., & Rath, G. (2019). Association of pro‐and anti‐inflammatory cytokines in preeclampsia. Journal of Clinical Laboratory Analysis, 33(4), e22834. https://doi.org/10.1002/jcla.22834
Bakrania, B. A., Hall, M. E., Shahul, S., & Granger, J. P. (2019). The Reduced Uterine Perfusion Pressure (RUPP) rat model of preeclampsia exhibits impaired systolic function and global longitudinal strain during pregnancy. Pregnancy Hypertension, 18, 169-172. https://doi.org/10.1016/j.preghy.2019.10.001
Bakrania, B. A., Spradley, F. T., Drummond, H. A., LaMarca, B., Ryan, M. J., & Granger, J. P. (2020). Preeclampsia: linking placental ischemia with maternal endothelial and vascular dysfunction. Comprehensive Physiology, 11(1), 1315. https://doi.org/10.1002%2Fcphy.c200008
Cornelius, D. C. (2018). Preeclampsia: from inflammation to immunoregulation. Clinical Medicine Insights: Blood Disorders, 11. https://doi.org/10.1177/1179545X17752325
Cunningham, M. W., Amaral, L. M., Campbell, N. E., Cornelius, D. C., Ibrahim, T., Vaka, V. R., & LaMarca, B. (2021). Investigation of interleukin-2-mediated changes in blood pressure, fetal growth restriction, and innate immune activation in normal pregnant rats and in a preclinical rat model of preeclampsia. Biology of Sex Differences, 12(1), 1-10. https://doi.org/10.1186/s13293-020-00345-0
Dechend, R., Lamarca, B., & Davidge, S. T. (2022). Salt, Aldosterone, and the Renin–Angiotensin System in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy, 335-353. https://doi.org/10.1016/B978-0-12-818417-2.00010-5
Gencheva, D., Nikolov, F., Uchikova, E., Mihaylov, R., Pencheva, B., & Vasileva, M. (2022). Interleukin-6 and its correlations with maternal characteristics and echocardiographic parameters in pre-eclampsia, gestational hypertension and normotensive pregnancy. Cardiovascular Journal of Africa, 33(2), 65-73. https://europepmc.org/article/pmc/pmc9364474
Granger, J. P., Spradley, F. T., & Bakrania, B. A. (2018). The endothelin system: a critical player in the pathophysiology of preeclampsia. Current Hypertension Reports, 20(4), 1-8. https://doi.org/10.1007/s11906-018-0828-4
Gronkowska, K. (2021). Aetiology, prophylaxis and management of preeclampsia. Acta Universitatis Lodziensis. Folia Biologica et Oecologica, 17, 111-121. https://doi.org/10.18778/1730-2366.16.22
Gumusoglu, S. B., Chilukuri, A. S., Santillan, D. A., Santillan, M. K., & Stevens, H. E. (2020). Neurodevelopmental outcomes of prenatal preeclampsia exposure. Trends in Neurosciences, 43(4), 253-268. https://doi.org/10.1016/j.tins.2020.02.003
Issotina Zibrila, A., Wang, Z., Ali, M. A., Osei, J. A., Sun, Y., Zafar, S., ... & Liu, J. (2021). Pyridostigmine ameliorates preeclamptic features in pregnant rats by inhibiting tumour necrosis factor-α synthetsis and antagonizing tumour necrosis factor-α-related effects. Journal of Hypertension, 39(9), 1774-1789. https://doi.org/10.1097/HJH.0000000000002932
Ives, C. W., Sinkey, R., Rajapreyar, I., Tita, A. T., & Oparil, S. (2020). Preeclampsia—pathophysiology and clinical presentations: JACC state-of-the-art review. Journal of the American College of Cardiology, 76(14), 1690-1702. https://doi.org/10.1016/j.jacc.2020.08.014
Jasovic Siveska, E. (2013). Preeclampsia: Should be Predict and Prevent?. Reprod Syst Sex Disord, 3(1). http://dx.doi.org/10.4172/2161-038X.1000e113
Lamarca, B., Brewer, J., & Wallace, K. (2011). IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?. International journal of interferon, cytokine and mediator research, 2011(3), 59–64. https://doi.org/10.2147/IJICMR.S16320
Levine, R. J., Maynard, S. E., Qian, C., Lim, K. H., England, L. J., Yu, K. F., ... & Karumanchi, S. A. (2004). Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine, 350(7), 672-683. https://doi.org/10.1056/NEJMoa031884
Mauro, A. K., Khurshid, N., Berdahl, D. M., Ampey, A. C., Adu, D., Shah, D. M., & Boeldt, D. S. (2021). Cytokine concentrations direct endothelial function in pregnancy and preeclampsia. Journal of Endocrinology, 248(2), 107-117. https://doi.org/10.1530/JOE-20-0397
Nair, S., & Salomon, C. (2018, September). Extracellular vesicles and their immunomodulatory functions in pregnancy. In Seminars in immunopathology (Vol. 40, No. 5, pp. 425-437). Springer Berlin Heidelberg. https://doi.org/10.1007/s00281-018-0680-2
Nakashima, A., Shima, T., Aoki, A., Kawaguchi, M., Yasuda, I., Tsuda, S., ... & Saito, S. (2021). Molecular and immunological developments in placentas. Human Immunology, 82(5), 317-324. https://doi.org/10.1016/j.humimm.2021.01.012
Nawaz, M., & Verma, M. K. (2020). Evaluation of Differential Levels of Serum Interleukin-6 in Pre-Eclamptic and Normal Pregnancy Women. Chairman, Editorial Board, 8(1), 53.
Negi, R., Haritha, V., Aziz, N., & Siddiqui, A. H. (2022). Biochemical markers in the pathogenesis of preeclampsia: novel link between placental growth factor and interleukin-6. Molecular and Cellular Biochemistry, 477(6), 1765-1774. https://doi.org/10.1007/s11010-022-04403-6
Prairie, E., Côté, F., Tsakpinoglou, M., Mina, M., Quiniou, C., Leimert, K., ... & Chemtob, S. (2021). The determinant role of IL-6 in the establishment of inflammation leading to spontaneous preterm birth. Cytokine & Growth Factor Reviews, 59, 118-130. https://doi.org/10.1016/j.cytogfr.2020.12.004
Raymond, D., & Peterson, E. (2011). A critical review of early-onset and late-onset preeclampsia. Obstetrical & Gynecological Survey, 66(8), 497-506. https://doi.org/10.1097/OGX.0b013e3182331028
Sani, H. M., Vahed, S. Z., & Ardalan, M. (2019). Preeclampsia: a close look at renal dysfunction. Biomedicine & Pharmacotherapy, 109, 408-416. https://doi.org/10.1016/j.biopha.2018.10.082
Setiawati, D. (2020). The Role of Inflammation in Pathogenesis of Preeclampsia: An Investigation of interleukin-6, interleukin 10, and the Ratio. International Journal of Medical Reviews and Case Reports, 4(10), 13-17. http://repositori.uin-alauddin.ac.id/id/eprint/20279
Sircar, M., Thadhani, R., & Karumanchi, S. A. (2015). Pathogenesis of preeclampsia. Current opinion in nephrology and hypertension, 24(2), 131-138. https://doi.org/10.1097/MNH.0000000000000105
Stepan, H., Hund, M., & Andraczek, T. (2020). Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome. Hypertension, 75(4), 918-926. https://doi.org/10.1161/HYPERTENSIONAHA.119.13763
Trivedi, C. D., Trivedi, D. J., & Sagare, A. A. (2013). Oxidant and antioxidant imbalance as root cause in preeclampsia. Banaswini Publishing.
Yagel, S., Cohen, S. M., & Goldman-Wohl, D. (2020). An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2020.10.023
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Biomedicine and Chemical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
